Status of Measles Elimination in Eleven Countries with High Routine Immunisation Coverage in The WHO African Region.

Journal of immunological sciences Pub Date : 2018-07-28
Balcha Masresha, Richard Luce, Messeret Shibeshi, Reggis Katsande, Amadou Fall, Joseph Okeibunor, Goitom Weldegebriel, Richard Mihigo
{"title":"Status of Measles Elimination in Eleven Countries with High Routine Immunisation Coverage in The WHO African Region.","authors":"Balcha Masresha, Richard Luce, Messeret Shibeshi, Reggis Katsande, Amadou Fall, Joseph Okeibunor, Goitom Weldegebriel, Richard Mihigo","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Measles elimination is defined as the absence of endemic measles virus transmission in a defined geographic area for at least 12 months in the presence of a well-performing surveillance system. The WHO framework for verification of measles elimination indicates that the achievement of measles and/or rubella elimination should be verified for individual countries.</p><p><strong>Objective: </strong>We identified 11 high performing countries based on their first dose measles vaccination coverage, and looked at their performance across the various programmatic parameters, to see if they are ready to undertake the verification of measles elimination.</p><p><strong>Methods: </strong>We identified 11 countries with >90% measles first dose coverage for the most recent 5 years according to the WHO UNICEF estimates of national immunisation coverage. We analysed vaccination coverage and surveillance performance in these countries.</p><p><strong>Results: </strong>Algeria, Botswana, Gambia, Mauritius, Rwanda, Seychelles have maintained measles first dose (MCV1) coverage of 95% or more since 2011. In 2015, only Algeria, Cape Verde and Seychelles had coverage of 95% or more for the second dose of measles vaccine (MCV2). Of the 22 supplemental immunisation activities (SIAs) among the 11 countries, only 6 had administrative coverage of less than 95%. Only Rwanda and Lesotho attained the case-based surveillance performance targets in all the five years.</p><p><strong>Conclusion: </strong>Despite their high routine first dose measles immunisation coverage, all of the 11 countries have some program gaps indicating that they do not meet all the criteria to undergo verification of elimination at this point. It is recommended for these countries to set up national verification committees as per the WHO framework for verification of measles elimination, in order to initiate the documentation and monitoring of progress, and to address programmatic gaps in the coming years.</p>","PeriodicalId":73785,"journal":{"name":"Journal of immunological sciences","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2018-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372061/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of immunological sciences","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Measles elimination is defined as the absence of endemic measles virus transmission in a defined geographic area for at least 12 months in the presence of a well-performing surveillance system. The WHO framework for verification of measles elimination indicates that the achievement of measles and/or rubella elimination should be verified for individual countries.

Objective: We identified 11 high performing countries based on their first dose measles vaccination coverage, and looked at their performance across the various programmatic parameters, to see if they are ready to undertake the verification of measles elimination.

Methods: We identified 11 countries with >90% measles first dose coverage for the most recent 5 years according to the WHO UNICEF estimates of national immunisation coverage. We analysed vaccination coverage and surveillance performance in these countries.

Results: Algeria, Botswana, Gambia, Mauritius, Rwanda, Seychelles have maintained measles first dose (MCV1) coverage of 95% or more since 2011. In 2015, only Algeria, Cape Verde and Seychelles had coverage of 95% or more for the second dose of measles vaccine (MCV2). Of the 22 supplemental immunisation activities (SIAs) among the 11 countries, only 6 had administrative coverage of less than 95%. Only Rwanda and Lesotho attained the case-based surveillance performance targets in all the five years.

Conclusion: Despite their high routine first dose measles immunisation coverage, all of the 11 countries have some program gaps indicating that they do not meet all the criteria to undergo verification of elimination at this point. It is recommended for these countries to set up national verification committees as per the WHO framework for verification of measles elimination, in order to initiate the documentation and monitoring of progress, and to address programmatic gaps in the coming years.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
世界卫生组织非洲地区常规免疫覆盖率较高的 11 个国家消除麻疹的现状。
背景:消除麻疹的定义是,在监测系统运行良好的情况下,在规定的地理区域内至少有 12 个月没有地方性麻疹病毒传播。世卫组织的消除麻疹核查框架指出,应核查各个国家实现消除麻疹和/或风疹的情况:我们根据其第一剂麻疹疫苗接种覆盖率确定了 11 个表现优异的国家,并考察了它们在各种计划参数方面的表现,以了解它们是否已准备好进行消除麻疹的核查:根据世界卫生组织、联合国儿童基金会对全国免疫接种覆盖率的估计,我们确定了最近 5 年麻疹疫苗首剂接种覆盖率大于 90% 的 11 个国家。我们对这些国家的疫苗接种覆盖率和监测表现进行了分析:自2011年以来,阿尔及利亚、博茨瓦纳、冈比亚、毛里求斯、卢旺达和塞舌尔的麻疹疫苗首剂(MCV1)接种率一直保持在95%或以上。2015 年,只有阿尔及利亚、佛得角和塞舌尔的麻疹疫苗第二剂(MCV2)接种率达到或超过 95%。在 11 个国家的 22 项补充免疫活动(SIA)中,只有 6 项活动的行政覆盖率低于 95%。只有卢旺达和莱索托在所有五年中都实现了病例监测绩效目标:尽管这 11 个国家的麻疹常规首剂免疫接种覆盖率很高,但所有这些国家都存在一些计划缺口,表明它们目前尚未达到接受消除麻疹核查的所有标准。建议这些国家按照世卫组织的消除麻疹核查框架成立国家核查委员会,以便开始记录和监测进展情况,并在未来几年解决计划差距问题。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Commentary: Early-in-life Isoflurane Exposure Alters Resting-State Functional Connectivity in Juvenile Non-human Primates - a Role for Neuroinflammation? Community Involvement in Response to Ebola Virus Disease Epidemic in North Kivu and Ituri, Democratic Republic of Congo: A Mixed-Methods Study. Epidemic Response amidst Insecurity: Addressing the Ebola Virus Epidemic in the Provinces of North Kivu and Ituri. Exploring Alternative Care Platforms for Symptomatic People in the Fight against the Ebola Virus Disease Outbreak. Perceptions and Rumors About the Ebola Virus Disease Vaccine in the Ituri and Kivu Provinces of the Democratic Republic of Congo.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1